12th AHA.24 Congress Coverage: Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy, SARAH Trial, by Dr. Alizade, Cardio-Oncologist.
🔹Stay tuned for more insights from the late-breaking trials